12+ hour, 37+ min ago  (61+ words) Nasdaq Else expects to provide further updates as these regulatory initiatives continue to evolve. Neither the TSX nor its regulation services provider (as that term is defined in the policies of the TSX) accept responsibility for the adequacy or accuracy…...

1+ mon, 2+ week ago  (51+ words) Dia Medica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, today announced that it has received a No Objection Letter from Health Canada for its Clinical Trial Application…...

7+ mon, 1+ week ago  (113+ words) -ELSE NUTRITION HOLDINGS INC. , today announced that it plans to host a business update conference call at 10: 00 a. m. Eastern Time on Tuesday, September 16, 2025 to discuss the Company's financial results for the second quarter of 2025 ended June 30, 2025, as well as the Company's…...

1+ mon, 1+ week ago  (607+ words) Pampers AMORE is Pampers" First New Diaper Brand for Newborns and Toddlers Since 2018 CINCINNATI--(BUSINESS WIRE)-- Pampers, the brand Behind Every Baby" known for its baby-first innovation and care, has introduced Pampers AMORE" " its most premium and most absorbent1 diaper. Created…...

2+ mon, 1+ day ago  (147+ words) Nasdaq -- Advances reimbursement strategy in the U. S. for Fema Seed, an intended first-step infertility treatment -- Learn more at www. femasys. com, or follow us on X, Facebook and Linked In. References1 Liu, J. H. , Glassner, M. , Gracia, C. R. , Johnstone, E. B. , Schnell, V. L. , Thomas, M. A. , L. Morrison, Lee-Sepsick, K. (2024). Fema Seed Directional…...

3+ mon, 2+ day ago  (117+ words) About This Event The Partnership for Maternal and Child Health of Northern New Jersey'visits the Nasdaq Market Site in Times Square in honor of Maternal Health Awareness Day. The Partnership is working to change the paradigm in maternal health and…...

7+ mon, 1+ week ago  (213+ words) --Biogen Inc. announced that the European Commission has granted marketing authorization for ZURZUVAE " to treat post-partum depression in adults following childbirth. "This approval is a major milestone in addressing a critical unmet need in maternal health for women in Europe,…...

5+ mon, 4+ week ago  (48+ words) --INVO Fertility, Inc. , a healthcare fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, today announced a strategic partnership with Heidi Health to integrate its innovative…...

6+ mon, 2+ week ago  (313+ words) The new tool empowers lower skilled healthcare workers to quickly and accurately calculate gestational age, without needing image interpretation or training, to expand ultrasound access in under-resourced Sub-Saharan Africa AI-Enabled Gestational Age Tool During pregnancy, ultrasound is a critical tool…...

9+ mon, 3+ week ago  (182+ words) June 30, 2025 " 09: 14 am EDT INVO Fertility adds PRP therapy to enhance fertility services, offering innovative treatment options for patients facing fertility challenges. PRP therapy uses a patient's own growth factors to stimulate uterine lining growth and ovarian rejuvenation, potentially improving fertility…...